Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Perivascular Epithelioid Cell Neoplasms × Biopsy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 77 Neoplasm Metastasis 56 Prostatic Neoplasms 54 Leukemia, Myeloid, Acute 47 Melanoma 45 Multiple Myeloma 42 Lung Neoplasms 40 Colorectal Neoplasms 38 Carcinoma, Non-Small-Cell Lung 36 Pancreatic Neoplasms 33 Lymphoma 31 Neoplasms 27 Leukemia, Lymphocytic, Chronic, B-Cell 27 Squamous Cell Carcinoma of Head and Neck 26 Myelodysplastic Syndromes 24 Ovarian Neoplasms 23 Triple Negative Breast Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 22 Lymphoma, Follicular 19 Uterine Cervical Neoplasms 17 Sarcoma 17 Burkitt Lymphoma 17 Stomach Neoplasms 16 Carcinoma, Renal Cell 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Myeloproliferative Disorders 15 Leukemia, Myelomonocytic, Chronic 15 Head and Neck Neoplasms 15 Glioma 15 Fallopian Tube Neoplasms 15

Interventions

Nivolumab 2 pazopanib 1 elacestrant 1 dactolisib 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 RAD1901 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Ifosfamide 1 Doxorubicin 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02334930 2016-08-22

PEC-Hem

University Hospital, Bordeaux

Hemangioma, Perivascular Epithelioid Cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡